Global Cannabis-based Medicines Market 2022 by Company, Regions, Type and Application, Forecast to 2028
The Cannabis-based Medicines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Cannabis-based Medicines market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Oral Solution accounting for % of the Cannabis-based Medicines global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While CBD (Cannabidiol) Based segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Cannabis-based Medicines include GW Pharmaceuticals plc, INSYS Therapeutics, Aequus Pharmaceuticals, Axim Biotechnologies, and Revive Therapeutics, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Cannabis-based Medicines market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
CBD (Cannabidiol) Based
THC (Tetrahydrocannabinol) Based
Others
Market segment by Application, can be divided into
Oral Solution
Tablets
Patches
Others
Market segment by players, this report covers
GW Pharmaceuticals plc
INSYS Therapeutics
Aequus Pharmaceuticals
Axim Biotechnologies
Revive Therapeutics
MGC Pharmaceuticals
ECHO Pharmaceuticals
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Cannabis-based Medicines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Cannabis-based Medicines, with revenue, gross margin and global market share of Cannabis-based Medicines from 2019 to 2022.
Chapter 3, the Cannabis-based Medicines competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Cannabis-based Medicines market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Cannabis-based Medicines research findings and conclusion, appendix and data source.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Cannabis-based Medicines
1.2 Classification of Cannabis-based Medicines by Type
1.2.1 Overview: Global Cannabis-based Medicines Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Cannabis-based Medicines Revenue Market Share by Type in 2021
1.2.3 CBD (Cannabidiol) Based
1.2.4 THC (Tetrahydrocannabinol) Based
1.2.5 Others
1.3 Global Cannabis-based Medicines Market by Application
1.3.1 Overview: Global Cannabis-based Medicines Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Oral Solution
1.3.3 Tablets
1.3.4 Patches
1.3.5 Others
1.4 Global Cannabis-based Medicines Market Size & Forecast
1.5 Global Cannabis-based Medicines Market Size and Forecast by Region
1.5.1 Global Cannabis-based Medicines Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Cannabis-based Medicines Market Size by Region, (2017-2022)
1.5.3 North America Cannabis-based Medicines Market Size and Prospect (2017-2028)
1.5.4 Europe Cannabis-based Medicines Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Cannabis-based Medicines Market Size and Prospect (2017-2028)
1.5.6 South America Cannabis-based Medicines Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Cannabis-based Medicines Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Cannabis-based Medicines Market Drivers
1.6.2 Cannabis-based Medicines Market Restraints
1.6.3 Cannabis-based Medicines Trends Analysis
2 Company Profiles
2.1 GW Pharmaceuticals plc
2.1.1 GW Pharmaceuticals plc Details
2.1.2 GW Pharmaceuticals plc Major Business
2.1.3 GW Pharmaceuticals plc Cannabis-based Medicines Product and Solutions
2.1.4 GW Pharmaceuticals plc Cannabis-based Medicines Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 GW Pharmaceuticals plc Recent Developments and Future Plans
2.2 INSYS Therapeutics
2.2.1 INSYS Therapeutics Details
2.2.2 INSYS Therapeutics Major Business
2.2.3 INSYS Therapeutics Cannabis-based Medicines Product and Solutions
2.2.4 INSYS Therapeutics Cannabis-based Medicines Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 INSYS Therapeutics Recent Developments and Future Plans
2.3 Aequus Pharmaceuticals
2.3.1 Aequus Pharmaceuticals Details
2.3.2 Aequus Pharmaceuticals Major Business
2.3.3 Aequus Pharmaceuticals Cannabis-based Medicines Product and Solutions
2.3.4 Aequus Pharmaceuticals Cannabis-based Medicines Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Aequus Pharmaceuticals Recent Developments and Future Plans
2.4 Axim Biotechnologies
2.4.1 Axim Biotechnologies Details
2.4.2 Axim Biotechnologies Major Business
2.4.3 Axim Biotechnologies Cannabis-based Medicines Product and Solutions
2.4.4 Axim Biotechnologies Cannabis-based Medicines Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Axim Biotechnologies Recent Developments and Future Plans
2.5 Revive Therapeutics
2.5.1 Revive Therapeutics Details
2.5.2 Revive Therapeutics Major Business
2.5.3 Revive Therapeutics Cannabis-based Medicines Product and Solutions
2.5.4 Revive Therapeutics Cannabis-based Medicines Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Revive Therapeutics Recent Developments and Future Plans
2.6 MGC Pharmaceuticals
2.6.1 MGC Pharmaceuticals Details
2.6.2 MGC Pharmaceuticals Major Business
2.6.3 MGC Pharmaceuticals Cannabis-based Medicines Product and Solutions
2.6.4 MGC Pharmaceuticals Cannabis-based Medicines Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 MGC Pharmaceuticals Recent Developments and Future Plans
2.7 ECHO Pharmaceuticals
2.7.1 ECHO Pharmaceuticals Details
2.7.2 ECHO Pharmaceuticals Major Business
2.7.3 ECHO Pharmaceuticals Cannabis-based Medicines Product and Solutions
2.7.4 ECHO Pharmaceuticals Cannabis-based Medicines Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 ECHO Pharmaceuticals Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Cannabis-based Medicines Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Cannabis-based Medicines Players Market Share in 2021
3.2.2 Top 10 Cannabis-based Medicines Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Cannabis-based Medicines Players Head Office, Products and Services Provided
3.4 Cannabis-based Medicines Mergers & Acquisitions
3.5 Cannabis-based Medicines New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Cannabis-based Medicines Revenue and Market Share by Type (2017-2022)
4.2 Global Cannabis-based Medicines Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Cannabis-based Medicines Revenue Market Share by Application (2017-2022)
5.2 Global Cannabis-based Medicines Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Cannabis-based Medicines Revenue by Type (2017-2028)
6.2 North America Cannabis-based Medicines Revenue by Application (2017-2028)
6.3 North America Cannabis-based Medicines Market Size by Country
6.3.1 North America Cannabis-based Medicines Revenue by Country (2017-2028)
6.3.2 United States Cannabis-based Medicines Market Size and Forecast (2017-2028)
6.3.3 Canada Cannabis-based Medicines Market Size and Forecast (2017-2028)
6.3.4 Mexico Cannabis-based Medicines Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Cannabis-based Medicines Revenue by Type (2017-2028)
7.2 Europe Cannabis-based Medicines Revenue by Application (2017-2028)
7.3 Europe Cannabis-based Medicines Market Size by Country
7.3.1 Europe Cannabis-based Medicines Revenue by Country (2017-2028)
7.3.2 Germany Cannabis-based Medicines Market Size and Forecast (2017-2028)
7.3.3 France Cannabis-based Medicines Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Cannabis-based Medicines Market Size and Forecast (2017-2028)
7.3.5 Russia Cannabis-based Medicines Market Size and Forecast (2017-2028)
7.3.6 Italy Cannabis-based Medicines Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Cannabis-based Medicines Revenue by Type (2017-2028)
8.2 Asia-Pacific Cannabis-based Medicines Revenue by Application (2017-2028)
8.3 Asia-Pacific Cannabis-based Medicines Market Size by Region
8.3.1 Asia-Pacific Cannabis-based Medicines Revenue by Region (2017-2028)
8.3.2 China Cannabis-based Medicines Market Size and Forecast (2017-2028)
8.3.3 Japan Cannabis-based Medicines Market Size and Forecast (2017-2028)
8.3.4 South Korea Cannabis-based Medicines Market Size and Forecast (2017-2028)
8.3.5 India Cannabis-based Medicines Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Cannabis-based Medicines Market Size and Forecast (2017-2028)
8.3.7 Australia Cannabis-based Medicines Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Cannabis-based Medicines Revenue by Type (2017-2028)
9.2 South America Cannabis-based Medicines Revenue by Application (2017-2028)
9.3 South America Cannabis-based Medicines Market Size by Country
9.3.1 South America Cannabis-based Medicines Revenue by Country (2017-2028)
9.3.2 Brazil Cannabis-based Medicines Market Size and Forecast (2017-2028)
9.3.3 Argentina Cannabis-based Medicines Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Cannabis-based Medicines Revenue by Type (2017-2028)
10.2 Middle East & Africa Cannabis-based Medicines Revenue by Application (2017-2028)
10.3 Middle East & Africa Cannabis-based Medicines Market Size by Country
10.3.1 Middle East & Africa Cannabis-based Medicines Revenue by Country (2017-2028)
10.3.2 Turkey Cannabis-based Medicines Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Cannabis-based Medicines Market Size and Forecast (2017-2028)
10.3.4 UAE Cannabis-based Medicines Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Cannabis-based Medicines Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Cannabis-based Medicines Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Cannabis-based Medicines Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Cannabis-based Medicines Revenue (USD Million) by Region (2017-2022)
Table 5. Global Cannabis-based Medicines Revenue Market Share by Region (2023-2028)
Table 6. GW Pharmaceuticals plc Corporate Information, Head Office, and Major Competitors
Table 7. GW Pharmaceuticals plc Major Business
Table 8. GW Pharmaceuticals plc Cannabis-based Medicines Product and Solutions
Table 9. GW Pharmaceuticals plc Cannabis-based Medicines Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. INSYS Therapeutics Corporate Information, Head Office, and Major Competitors
Table 11. INSYS Therapeutics Major Business
Table 12. INSYS Therapeutics Cannabis-based Medicines Product and Solutions
Table 13. INSYS Therapeutics Cannabis-based Medicines Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Aequus Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 15. Aequus Pharmaceuticals Major Business
Table 16. Aequus Pharmaceuticals Cannabis-based Medicines Product and Solutions
Table 17. Aequus Pharmaceuticals Cannabis-based Medicines Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Axim Biotechnologies Corporate Information, Head Office, and Major Competitors
Table 19. Axim Biotechnologies Major Business
Table 20. Axim Biotechnologies Cannabis-based Medicines Product and Solutions
Table 21. Axim Biotechnologies Cannabis-based Medicines Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Revive Therapeutics Corporate Information, Head Office, and Major Competitors
Table 23. Revive Therapeutics Major Business
Table 24. Revive Therapeutics Cannabis-based Medicines Product and Solutions
Table 25. Revive Therapeutics Cannabis-based Medicines Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. MGC Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 27. MGC Pharmaceuticals Major Business
Table 28. MGC Pharmaceuticals Cannabis-based Medicines Product and Solutions
Table 29. MGC Pharmaceuticals Cannabis-based Medicines Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. ECHO Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 31. ECHO Pharmaceuticals Major Business
Table 32. ECHO Pharmaceuticals Cannabis-based Medicines Product and Solutions
Table 33. ECHO Pharmaceuticals Cannabis-based Medicines Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Global Cannabis-based Medicines Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 35. Global Cannabis-based Medicines Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 36. Breakdown of Cannabis-based Medicines by Company Type (Tier 1, Tier 2 and Tier 3)
Table 37. Cannabis-based Medicines Players Head Office, Products and Services Provided
Table 38. Cannabis-based Medicines Mergers & Acquisitions in the Past Five Years
Table 39. Cannabis-based Medicines New Entrants and Expansion Plans
Table 40. Global Cannabis-based Medicines Revenue (USD Million) by Type (2017-2022)
Table 41. Global Cannabis-based Medicines Revenue Share by Type (2017-2022)
Table 42. Global Cannabis-based Medicines Revenue Forecast by Type (2023-2028)
Table 43. Global Cannabis-based Medicines Revenue by Application (2017-2022)
Table 44. Global Cannabis-based Medicines Revenue Forecast by Application (2023-2028)
Table 45. North America Cannabis-based Medicines Revenue by Type (2017-2022) & (USD Million)
Table 46. North America Cannabis-based Medicines Revenue by Type (2023-2028) & (USD Million)
Table 47. North America Cannabis-based Medicines Revenue by Application (2017-2022) & (USD Million)
Table 48. North America Cannabis-based Medicines Revenue by Application (2023-2028) & (USD Million)
Table 49. North America Cannabis-based Medicines Revenue by Country (2017-2022) & (USD Million)
Table 50. North America Cannabis-based Medicines Revenue by Country (2023-2028) & (USD Million)
Table 51. Europe Cannabis-based Medicines Revenue by Type (2017-2022) & (USD Million)
Table 52. Europe Cannabis-based Medicines Revenue by Type (2023-2028) & (USD Million)
Table 53. Europe Cannabis-based Medicines Revenue by Application (2017-2022) & (USD Million)
Table 54. Europe Cannabis-based Medicines Revenue by Application (2023-2028) & (USD Million)
Table 55. Europe Cannabis-based Medicines Revenue by Country (2017-2022) & (USD Million)
Table 56. Europe Cannabis-based Medicines Revenue by Country (2023-2028) & (USD Million)
Table 57. Asia-Pacific Cannabis-based Medicines Revenue by Type (2017-2022) & (USD Million)
Table 58. Asia-Pacific Cannabis-based Medicines Revenue by Type (2023-2028) & (USD Million)
Table 59. Asia-Pacific Cannabis-based Medicines Revenue by Application (2017-2022) & (USD Million)
Table 60. Asia-Pacific Cannabis-based Medicines Revenue by Application (2023-2028) & (USD Million)
Table 61. Asia-Pacific Cannabis-based Medicines Revenue by Region (2017-2022) & (USD Million)
Table 62. Asia-Pacific Cannabis-based Medicines Revenue by Region (2023-2028) & (USD Million)
Table 63. South America Cannabis-based Medicines Revenue by Type (2017-2022) & (USD Million)
Table 64. South America Cannabis-based Medicines Revenue by Type (2023-2028) & (USD Million)
Table 65. South America Cannabis-based Medicines Revenue by Application (2017-2022) & (USD Million)
Table 66. South America Cannabis-based Medicines Revenue by Application (2023-2028) & (USD Million)
Table 67. South America Cannabis-based Medicines Revenue by Country (2017-2022) & (USD Million)
Table 68. South America Cannabis-based Medicines Revenue by Country (2023-2028) & (USD Million)
Table 69. Middle East & Africa Cannabis-based Medicines Revenue by Type (2017-2022) & (USD Million)
Table 70. Middle East & Africa Cannabis-based Medicines Revenue by Type (2023-2028) & (USD Million)
Table 71. Middle East & Africa Cannabis-based Medicines Revenue by Application (2017-2022) & (USD Million)
Table 72. Middle East & Africa Cannabis-based Medicines Revenue by Application (2023-2028) & (USD Million)
Table 73. Middle East & Africa Cannabis-based Medicines Revenue by Country (2017-2022) & (USD Million)
Table 74. Middle East & Africa Cannabis-based Medicines Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Cannabis-based Medicines Picture
Figure 2. Global Cannabis-based Medicines Revenue Market Share by Type in 2021
Figure 3. CBD (Cannabidiol) Based
Figure 4. THC (Tetrahydrocannabinol) Based
Figure 5. Others
Figure 6. Cannabis-based Medicines Revenue Market Share by Application in 2021
Figure 7. Oral Solution Picture
Figure 8. Tablets Picture
Figure 9. Patches Picture
Figure 10. Others Picture
Figure 11. Global Cannabis-based Medicines Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 12. Global Cannabis-based Medicines Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Cannabis-based Medicines Revenue Market Share by Region (2017-2028)
Figure 14. Global Cannabis-based Medicines Revenue Market Share by Region in 2021
Figure 15. North America Cannabis-based Medicines Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Europe Cannabis-based Medicines Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Asia-Pacific Cannabis-based Medicines Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. South America Cannabis-based Medicines Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Middle East and Africa Cannabis-based Medicines Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Cannabis-based Medicines Market Drivers
Figure 21. Cannabis-based Medicines Market Restraints
Figure 22. Cannabis-based Medicines Market Trends
Figure 23. GW Pharmaceuticals plc Recent Developments and Future Plans
Figure 24. INSYS Therapeutics Recent Developments and Future Plans
Figure 25. Aequus Pharmaceuticals Recent Developments and Future Plans
Figure 26. Axim Biotechnologies Recent Developments and Future Plans
Figure 27. Revive Therapeutics Recent Developments and Future Plans
Figure 28. MGC Pharmaceuticals Recent Developments and Future Plans
Figure 29. ECHO Pharmaceuticals Recent Developments and Future Plans
Figure 30. Global Cannabis-based Medicines Revenue Share by Players in 2021
Figure 31. Cannabis-based Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 32. Global Top 3 Players Cannabis-based Medicines Revenue Market Share in 2021
Figure 33. Global Top 10 Players Cannabis-based Medicines Revenue Market Share in 2021
Figure 34. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 35. Global Cannabis-based Medicines Revenue Share by Type in 2021
Figure 36. Global Cannabis-based Medicines Market Share Forecast by Type (2023-2028)
Figure 37. Global Cannabis-based Medicines Revenue Share by Application in 2021
Figure 38. Global Cannabis-based Medicines Market Share Forecast by Application (2023-2028)
Figure 39. North America Cannabis-based Medicines Sales Market Share by Type (2017-2028)
Figure 40. North America Cannabis-based Medicines Sales Market Share by Application (2017-2028)
Figure 41. North America Cannabis-based Medicines Revenue Market Share by Country (2017-2028)
Figure 42. United States Cannabis-based Medicines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Cannabis-based Medicines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Cannabis-based Medicines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Cannabis-based Medicines Sales Market Share by Type (2017-2028)
Figure 46. Europe Cannabis-based Medicines Sales Market Share by Application (2017-2028)
Figure 47. Europe Cannabis-based Medicines Revenue Market Share by Country (2017-2028)
Figure 48. Germany Cannabis-based Medicines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Cannabis-based Medicines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Cannabis-based Medicines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Cannabis-based Medicines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Cannabis-based Medicines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Cannabis-based Medicines Sales Market Share by Type (2017-2028)
Figure 54. Asia-Pacific Cannabis-based Medicines Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Cannabis-based Medicines Revenue Market Share by Region (2017-2028)
Figure 56. China Cannabis-based Medicines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Cannabis-based Medicines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. South Korea Cannabis-based Medicines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Cannabis-based Medicines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Cannabis-based Medicines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Cannabis-based Medicines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Cannabis-based Medicines Sales Market Share by Type (2017-2028)
Figure 63. South America Cannabis-based Medicines Sales Market Share by Application (2017-2028)
Figure 64. South America Cannabis-based Medicines Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Cannabis-based Medicines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Cannabis-based Medicines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East and Africa Cannabis-based Medicines Sales Market Share by Type (2017-2028)
Figure 68. Middle East and Africa Cannabis-based Medicines Sales Market Share by Application (2017-2028)
Figure 69. Middle East and Africa Cannabis-based Medicines Revenue Market Share by Country (2017-2028)
Figure 70. Turkey Cannabis-based Medicines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Saudi Arabia Cannabis-based Medicines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. UAE Cannabis-based Medicines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Methodology
Figure 74. Research Process and Data Source
